Understanding urinary tract infections caused by resistant bacteria
Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacteria: Management by General Practitioners in Bas-Rhin.
This study looks at how doctors in the Bas-Rhin region treat urinary tract infections caused by hard-to-treat bacteria to see if there are better ways to help patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Trial ID | NCT06910878 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on urinary tract infections (UTIs) caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E), which are increasingly resistant to common antibiotics. It aims to analyze how general practitioners in the Bas-Rhin region manage these infections and identify potential improvements in treatment approaches. The study will involve adult patients diagnosed with ESBL-E UTIs in a primary care setting between June and December 2024, with data collected from their medical records and physician input.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with a confirmed Enterobacteriaceae urinary tract infection treated in a primary care setting.
Not a fit: Patients who do not have a urinary tract infection or those whose primary care physician does not agree to participate may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for UTIs caused by resistant bacteria, enhancing patient outcomes.
How similar studies have performed: While the specific approach of this study is observational and focused on a regional context, similar studies addressing antibiotic resistance in UTIs have shown promising results in improving treatment protocols.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult (≥18 years old) * Subject with an Enterobacteriaceae urinary tract infection treated in a primary care setting for urinary tract infection between June 1, 2024 and December 31, 2024 * Subject not objecting, after being informed, to the reuse of their data for the purposes of this research. * The subject's primary care physician agreeing to participate in the study Exclusion Criteria: * Subject and/or their primary care physician having expressed their opposition to participating in the study * Subject under legal protection * Subject under guardianship or curatorship
Where this trial is running
Strasbourg
- Service de maladies infectieuses et tropicales - Hôpitaux Universitaires de Strasbourg — Strasbourg, France (Recruiting)
Study contacts
- Study coordinator: Yves HANSMANN, MD, PhD
- Email: yves.hansmann@chru-strasbourg.fr
- Phone: 33 3 69 55 09 78
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.